Levels of soluble adhesion molecules among normotensive and hypertensive type 2 diabetic patients;Niveles de moléculas de adhesión solubles en pacientes diabéticos tipo 2 normotensos e hipertensos

Gaceta Medica de Mexico

Volumn 144, Issue 1, 2008, Pages 11-14

  Rubio Guerra, Alberto Francisco ^a,d   Vargas Robles, Hilda ^b   Medina Santillán, Roberto ^c   Escalante Acosta, Bruno Alfonso ^b  

^a Hospital General de Ticoman SS DF   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d NONE   (Mexico)

Author keywords

Adhesion molecules; Endothelial dysfunction; Hypertension; Type 2 diabetes

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; E-SELECTIN; FEMALE; HUMANS; HYPERTENSION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 50849101070     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Todd R, Lee RW. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: Mechanisms and Management. Ann Intern Med 2003;139:824-834.
2. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:29-38.
3. Valen G, Yan Z, Hanson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001;38:307-314.
4. De Winter MPJ. Kanters E. Kraal G. Hofker MH. Nuclear factor kB signaling in atherogenesis, Arterioscler Thromb Vasc Biol 2005;25:904-914.
5. Rubio AF, Robles H, Vargas G, Escalante BA. Correlation between circulating adhesion molecules levels and albuminuria in type-2 diabetic normotensive patients. Med Sci Monit 2007;13:349-352.
6. Shoelson S, Lee J, Goldfine A. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801.
7. Frenette PS, Wagner DD. Adhesion molecules-part I.N Engl J Med 1996;334:1526-1529.
8. Frenette PS, Wagner DD. Adhesion molecules-part II. Blood Vessels and blood cells. N Engl J Med 1996;335:43-45.
9. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1685-1695.
10. Galen FX. Cell adhesion molecules in hypertension: endothelial markers of vascular injury and predictors of target organ damage? J hypertens 2002;20:813-816.
11. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949.
12. Lobby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
13. Boulbou MS, Koukoulis GN, Makri ED, Petinaki EA, Gourgoulianis KI, Germenis AE. Circulting adhesion molecules in type 2 diabetes mellitus and hypertension. Int J Cardiol 2005;98:39-44.
14. Gasic S, Wagner O, Fasching P, Ludwig C, Veitl M, Kapiotis S, et al. Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type 2 diabetic patients with microalbuminuria. Am J hypertens 1999;12:217-222.
15. Matsumoto K, Sera Y, Nakamura H, Ueki Y, Miyake S. Serum concentrations of soluble adhesion molecules are related to degree of hyperglucemia and insulin resistance in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2002;55:131-138.
16. American Diabetes Association. Standards of Medical Care in Diabetes-2007. Diabetes care 2007;30:S4-S41.
17. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes GR. C-reactive protein, interleukin-6 and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population. Circulation 2005;112:976-983.
18. Yamagushi M, Suwa H, Miyasaka M, Kumada K. Selective inhibition of vascular cell adhesion molecule-1 expression by verapamil in human vascular endothelial cells. Transplantation 1997;63:759-764.
19. Eurico DT, Majumdar SR, Tsuyuki RT. Johnson JA. Reduced mortality associated with the use of ACE inhibitors in patients with type-2 diabetes. Diabetes care 2004;27:1330-1334.
20. Rubio AF, Arceo A, Vargas G, Rodríguez L, Lozano JJ, Treviño C. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes. Diabetes care 2004;27;1688-1691.